Clinical Trial: Efficacy of Pancrelipase on Postprandial Belching and Bloating.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.
Detailed Summary: Subjects will complete a double-blind crossover study in which, for one week periods, they will receive two pancrelipase tablets with each of the three major meals or a similarly administered identical placebo. Three times daily, subjects will rate the severity of belching, epigastric discomfort, epigastric fullness, bloating, and nausea.
Sponsor: Solvay Pharmaceuticals
Current Primary Outcome:
- Abdominal bloating
- Abdominal pain
- Eructation
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Minneapolis Veterans Affairs Medical Center
Dates:
Date Received: December 15, 2005
Date Started: January 2000
Date Completion: October 2000
Last Updated: December 15, 2005
Last Verified: December 2000
